MARKET

AMGN

AMGN

Amgen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

232.82
-0.95
-0.41%
Closed 18:55 12/09 EST
OPEN
234.96
PREV CLOSE
233.77
HIGH
235.05
LOW
232.63
VOLUME
1.91M
TURNOVER
--
52 WEEK HIGH
235.80
52 WEEK LOW
166.30
MARKET CAP
138.34B
P/E (TTM)
17.87
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AMGN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AMGN News

  • Stocks Hold Against Resistance
  • Investopedia.7h ago
  • Big biotech deals: 5 trades
  • CNBC.com.9h ago
  • Healthpeak in lease amendment, extension with Amgen
  • Seeking Alpha - Article.10h ago
  • Beyond Cholesterol: Landmark deCODE Study Elucidates Role of Lipoprotein(a) as Major Risk Factor for Heart Disease
  • PR Newswire.12h ago

More

Industry

Pharmaceuticals
+0.14%
Pharmaceuticals & Medical Research
+0.23%

Hot Stocks

Name
Price
%Change

About AMGN

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.
More

Webull offers Amgen, Inc. (AMGN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.